Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can tailored rehab after ACL surgery keep athletes safer?

NCT ID NCT05323474

Prevention Sponsor: Centre Hospitalier Universitaire de Saint Etienne Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a personalized, monthly-checked rehab program from 3 to 6 months after ACL surgery can lower the chance of re-tearing the ligament or injuring the other knee. About 432 athletes who want to return to competitive sports will be randomly assigned to either standard rehab or the optimized program. The goal is to see if the tailored approach reduces new ACL injuries compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
personalized rehabilitation program
What this could lead to
If it works, this could provide a better rehab plan to prevent re-tearing the ACL or injuring the other knee after surgery.
What could go wrong
This is a mid-sized trial, and results may not apply to all athletes. The personalized program is more intensive, and some patients may not follow it fully.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 432 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2022

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 25 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Affiliation to the French Social Security system * Patient who has had an ACL reconstruction regardless of the standard surgical technique used * Patient with a sports activity, pivot and/or contact (e.g. soccer, basketball, handball, rugby, judo...) and practiced in competition (Tegner sports activity scores \>7 and Marx scores \>11 before the accident. * Patient wishing to return to competitive sport * Consent signed by the patient Exclusion Criteria: * Contralateral or bilateral involvement or operated on for a re-injury of the ACL * Patients with a medical contraindication to the performance of one of the tests * Patients suffering from a neurological (motor and/or sensitive), vestibular or rheumatic pathology * Patient performing rehabilitation with a physiotherapist who does not wish to participate in the study. * Pregnant or breastfeeding woman * Patient under guardianship or curators

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anterior cruciate ligament rupture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Anterior Cruciate Ligament Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anterior cruciate ligament rupture Ligament knee injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de Saint-Etienne

    RECRUITING

    Saint-Etienne, 42055, France

  • Centre Hospitalier de Firminy

    NOT_YET_RECRUITING

    Firminy, France

  • Clinique de Domont Ortholab

    NOT_YET_RECRUITING

    Domont, 95330, France

  • Clinique de La Sauvegarde

    RECRUITING

    Lyon, 69000, France

  • Hopital de La Croix Rousse

    NOT_YET_RECRUITING

    Lyon, 69000, France

  • Hôpital Lyon Sud

    NOT_YET_RECRUITING

    Lyon, 69495, France

  • Hôpital de la Tour

    NOT_YET_RECRUITING

    Geneva, Switzerland

  • Medipole de Savoie

    RECRUITING

    Challes-les-Eaux, 73000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.